Kaldyum

Potassium Chloride, the active ingredient in Kaldyum, is an electrolyte supplement presented as an oral formulation for oral use. It replenishes potassium ions to correct hypokalemia and maintain normal cellular function in patients with potassium deficiency.

GNH USA supplies Kaldyum as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Kaldyum is used as an oral electrolyte supplement to address conditions associated with low potassium levels.

- Hypokalemia: restores normal serum potassium concentrations. - Potassium deficiency: corrects depleted potassium stores. - Cardiac arrhythmia risk due to low potassium: helps maintain cardiac electrical stability.

Potassium Chloride may cause a range of adverse reactions, most of which are mild and transient.

Common Side Effects: - Nausea: mild to moderate stomach upset. - Vomiting: occasional emesis after dosing. - Abdominal discomfort: cramping or pain. - Diarrhea: loose stools. - Taste alteration: metallic or salty taste. - Flatulence: increased gas.

Serious or Rare Side Effects: - Hyperkalemia: dangerously high serum potassium. - Cardiac arrhythmias: irregular heart rhythms. - Severe allergic reaction: rash, swelling, or anaphylaxis. - Muscle weakness: profound weakness or paralysis. - Respiratory distress: shortness of breath. - Kidney injury: impaired renal function in susceptible patients.

When prescribing Kaldyum, clinicians should consider several safety measures.

- Serum potassium monitoring: check levels before and during therapy. - Renal function assessment: adjust dose in patients with impaired kidneys. - Concomitant ACE inhibitor use: watch for additive potassium rise. - Existing hyperkalemia: avoid use if serum potassium is already elevated. - Drug‑induced potassium retention: caution with potassium‑sparing diuretics. - Store at below 25°C: keep in the original container, protect from moisture and direct sunlight.

Potassium Chloride can interact with several medications, requiring careful management.

Major Interactions (Avoid): - ACE inhibitors: may cause excessive potassium accumulation. - Angiotensin II receptor blockers (ARBs): increase risk of hyperkalemia. - Potassium‑sparing diuretics: additive potassium effect. - NSAIDs: can impair renal potassium excretion. - Trimethoprim‑sulfamethoxazole: may raise serum potassium.

Moderate Interactions (Monitor Closely): - Digoxin: heightened risk of toxicity with high potassium. - Beta‑blockers: may mask symptoms of hyperkalemia. - Lithium: altered renal clearance. - Corticosteroids: affect potassium balance. - Certain antibiotics (e.g., aminoglycosides): renal function impact.